ANTIVIRAL ACTIVITIES OF PYROPHOSPHATE ANALOGUES: A NEW ANTIHERPETIC DRUG, FOSCARNETHELGSTRAND E; LERNESTEDT JO; OEBERG B et al.1981; DRUGS EXP. CLIN. RES.; ISSN 0378-6501; CHE; DA. 1981; VOL. 7; NO 3; PP. 327-330; BIBL. 14 REF.Article

PENILE EROSIONS ASSOCIATED WITH FOSCARNET THERAPY IN A CHILDHICK, Ryan W; PROSE, Neil.Pediatric dermatology. 2010, Vol 27, Num 3, pp 302-303, issn 0736-8046, 2 p.Article

Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replicationGADLER, H.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 3, pp 370-374, issn 0066-4804Article

THERAPEUTIC EFFECTS OF FOSCARNET SODIUM AND ACYCLOVIR ON CUTANEOUS INFECTIONS DUE TO HERPES SIMPLEX VIRUS TYPE 1 IN GUINEA PIGSALENIUS S; BERG M; BROBERG F et al.1982; J. INFECT. DIS.; ISSN 0022-1899; USA; DA. 1982; VOL. 145; NO 4; PP. 569-573; BIBL. 15 REF.Article

Wirksamkeit und Verträglichkeit von topisch appliziertem Foscarnet-Natrium bei der Behandlung von Herpes Labialis : Ergebnisse einer Anwendungsbeobachtung = Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of post-marketing surveillanceGROSS, G; BRAUN, D.Hautarzt. 2006, Vol 57, Num 1, pp 40-46, issn 0017-8470, 7 p.Article

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)OBERG, B.Pharmacology & therapeutics (Oxford). 1982, Vol 19, Num 3, pp 387-415, issn 0163-7258Article

Crystallization After Intravitreous Foscarnet InjectionsMARTINEZ-CASTILLO, Sebastián; MARIN-LAMBIES, Cristina; GALLEGO-PINAZO, Roberto et al.Archives of ophthalmology (1960). 2012, Vol 130, Num 5, pp 658-659, issn 0003-9950, 2 p.Article

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblastsNAESENS, Lieve; BONNAFOUS, Pascale; AGUT, Henri et al.Journal of clinical virology. 2006, Vol 37, issn 1386-6532, S69-S75, SUP1Conference Paper

Is combination antiviral therapy for CMV superior to monotherapy? : CMV. Part IIIDREW, W. Lawrence.Journal of clinical virology. 2006, Vol 35, Num 4, pp 485-488, issn 1386-6532, 4 p.Article

Different mutations in the HHV 6 DNA polymerase gene accounting for resistance to foscarnetBONNAFOUS, Pascale; NAESENS, Lieve; PETRELLA, Stéphanie et al.Antiviral therapy (London). 2007, Vol 12, Num 6, pp 877-888, issn 1359-6535, 12 p.Article

Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapyBESTMAN-SMITH, Julie; BOIVIN, Guy.Journal of medical virology. 2002, Vol 67, Num 1, pp 88-91, issn 0146-6615Article

Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotypeVISSE, B; HURAUX, J.-M; FILLET, A.-M et al.Journal of medical virology. 1999, Vol 59, Num 1, pp 84-90, issn 0146-6615Article

Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cellsKINI, G. D; HOSTETLER, S. E; BEADLE, J. R et al.Antiviral research. 1997, Vol 36, Num 2, pp 115-124, issn 0166-3542Article

Generation of hydroxyl radicals by the antiviral compound Phosphonoformic acid (foscarnet)LINDQVIST, Christer; NORDSTRÖM, Tommy.Pharmacology & toxicology. 2001, Vol 89, Num 1, pp 49-55, issn 0901-9928Article

Foscarnet-associated eosinophilic folliculitis in a patient with AIDSROOS, Thomas C; ALBRECHT, Helmut.Journal of the American Academy of Dermatology. 2001, Vol 44, Num 3, pp 546-547, issn 0190-9622Article

Foscarnet: an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?ORDEMANN, R; NAUMANN, R; GEISSLER, G et al.Annals of hematology (Print). 2000, Vol 79, Num 8, pp 432-436, issn 0939-5555Article

Transient foscarnet-induced hypercalcaemiaBARBA, R; GOMEZ-RODRIGO, J; MARCO, J et al.AIDS (London). 1998, Vol 12, Num 14, pp 1930-1931, issn 0269-9370Article

A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strainsPRIX, L; MAIERL, J; JAHN, G et al.Journal of clinical virology. 1998, Vol 11, Num 1, pp 29-37, issn 1386-6532Article

Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistanceLIPSON, S. M; SONI, M; BIONDO, F. X et al.Diagnostic microbiology and infectious disease. 1997, Vol 28, Num 3, pp 123-129, issn 0732-8893Article

Resistance to antivirals in human cytomegalovirus : mechanisms and clinical significance : Frontiers in antimicrobial resistancePEREZ, J. L.Microbiologia (Madrid). 1997, Vol 13, Num 3, pp 343-352, issn 0213-4101Article

FoscarnetLa Revue Prescrire. 1996, Vol 16, Num 168, pp 839-841, issn 0247-7750Article

In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnetGARRE, B; VAN DER MEULEN, K; NUGENT, J et al.Veterinary microbiology (Amsterdam). 2007, Vol 122, Num 1-2, pp 43-51, issn 0378-1135, 9 p.Article

A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnetDUCANCELLE, Alexandra; CHAMPIER, Gaël; ALAIN, Sophie et al.Antiviral therapy (London). 2006, Vol 11, Num 4, pp 537-540, issn 1359-6535, 4 p.Article

Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replicationSELLESETH, Dean W; TALARICO, Christine L; MILLER, Teresa et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 4, pp 1468-1471, issn 0066-4804, 4 p.Article

Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitisWEINBERG, Adriana; JABS, Douglas A; CHOU, Sunwen et al.The Journal of infectious diseases. 2003, Vol 187, Num 5, pp 777-784, issn 0022-1899, 8 p.Article